Vergleich

PLA2G4A, Recombinant, Human (Cytosolic Phospholipase A2, cPLA2, Phospholipase A2 Group IVA, Phospholipase A2, Phosphatidylcholine 2-acylhydrolase, Lysophospholipase, PLA2G4, CPLA2)

ArtNr USB-P4074-03R
Hersteller United States Biological
Menge 10 ug
Kategorie
Typ Enzymes
Format Liquid
Specific against other
Purity ≥80% by SDS-PAGE under reducing conditions and visualized by silver stain and quantitative densitometry by Coomassie Blue stain Endotoxin: ≤1EU/ug (LAL)
ECLASS 10.1 32160410
ECLASS 11.0 32160410
UNSPSC 12352204
Versandbedingung Gekühlt
Lieferbar
Manufacturer - Category
Molecular Biology / MB-Enzymes, Phospholipase
Shipping Temperature
Blue Ice
Storage Conditions
-20°C
Molecular Weight
86
Grade
Purified
Form
Supplied as a liquid in 25mM Tris, 500mM sodium chloride, pH 7.5, 1mM TCEP, 0.02% Brij-35, 20% glycerol.
EU Commodity Code
30021019
Description
Cytosolic Phospholipase A2a (PLA2G4A) belongs to the group IV phospholipase A2 family. These enzymes hydrolyze the ester bond at the second position (sn-2) of membrane glycerophospholipids. The group IV phospholipase A2 (PLA2G4) family is comprised of six intracellular enzymes. PLA2G4A has a preference for arachidonic acid in the sn-2 position of phospholipids indicating its involvement in the metabolism of eicosanoids. Its active site is characterized by a serine and aspartic acid dyad. The overall structural feature displays two domains, a lipid binding C2 domain and a catalytic a/b hydrolase domain. PLA2G4A translocation to the membrane and activation is facilitated by a calcium-ion dependent conformational change in its C2 domain. In addition, phosphorylation of serine residues in PLA2G4A by protein kinases may be another regulatory mechanism for promoting the release of arachidonic acid. The knockout mouse studies of this enzyme indicate that the enzyme may play a major role in inflammatory diseases. Genetic ablation or reduction of PLA2G4A protected human amyloid precursor protein (APP) related pathogenesis from a mouse model. Mouse model studies of brain and lung cancer indicates that PLA2G4A may play a key regulatory role in angiogenesis of these tumors.

Recombinant protein corresponding to Met1-Ala749 from human PLA2G4A fused with 6-His-tag at C-terminal expressed in Sf21 cells. Accession Number: NP_077734

Molecular Weight:
~86kD

Biological Activity:
Measured by its ability to hydrolyze 1-Hexadecanoyl-2-(1-pyrene-decanoyl)-sn-glycero-3-phosphocholine.

Specific Activity:
≥15pmol/min/µg

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Shelf Life
6 months

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 10 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen